Results 91 to 100 of about 15,215 (194)
Resent clinical studies have revealed that the M 1 /M 4 preferring mAChR agonist xanomeline induces a robust antipsychotic effect in schizophrenic patients, suggesting that mAChR agonists may be efficacious in reducing psychotic symptoms in patients ...
Ashley Elizabeth Brady +5 more
openaire +1 more source
Rhythmic brain activity is critical to many brain functions and is sensitive to neuromodulation, but so far very few studies have investigated this activity on the cellular level in vitro in human brain tissue samples.
Danqing Yang +7 more
doaj +1 more source
Although clozapine-N-oxide (CNO), a major metabolite of clozapine (CLZ), is a widely used agonist of designer receptors exclusively activated by designer drugs (DREADDs), the compound responsible for visualizing or activating DREADDs in nuclear medicine ...
Jian Wang +14 more
doaj +1 more source
Allosteric Modulators of the M4 Muscarinic Acetylcholine Receptor [PDF]
openaire +4 more sources
555. M4 MUSCARINIC RECEPTOR ACTIVATION IN THE CENTRAL AMYGDALA REDUCES STRESS-INDUCED ALCOHOL SEEKING IN ALCOHOL PREFERRING RATS [PDF]
Background Stress is a key factor contributing to relapse, a major hurdle in the treatment of alcohol use disorders. A region key to brain stress systems and essential for emotional regulation is the central amygdala, and alcohol dependence has been ...
R. Anversa +3 more
europepmc +2 more sources
Muscarinic acetylcholine receptor M4 (CHRM4; HM4) [PDF]
openaire +1 more source
Several therapeutics and biomarkers that target Alzheimer's disease (AD) are under development. Our clinical positron emission tomography (PET) research programs are interested in six radiopharmaceuticals to image patients with AD and related dementias ...
Faustine d'Orchymont +6 more
semanticscholar +1 more source
From schizophrenia to dementia: Is Cobenfy a potential treatment for behavioral and psychological symptoms of dementia? [PDF]
Golden JC, Murphy KS, Tampi RR.
europepmc +1 more source
Targeting disrupted networks in schizophrenia: Can muscarinic drugs make a fundamental difference? [PDF]
Pratt JA, Morris BJ.
europepmc +1 more source
An SstI polymorphism for the human muscarinic acetylchoilne receptor gene, m4 (CHRM 4)
S D, Detera-Wadleigh +2 more
openaire +3 more sources

